Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5101
Xencor
XNCR
$1.74B
| $2.39M | ﹤0.01% |
87,256
+67,316
| +338% | +$1.66M |
|
|
LTC
5102
CALL
LTC Properties
LTC
$2.17B
| $2.38M | ﹤0.01% |
62,100
+53,000
| +582% | +$1.96M |
|
5103
PUT
Alcon
ALC
$35.9B
| $2.38M | ﹤0.01% |
34,100
-86,500
| -72% | -$6.31M |
|
5104
Cheniere Energy
CQP
$33.4B
| $2.38M | ﹤0.01% |
53,100
+11,161
| +27% | +$587K |
|
|
ONCR
5105
DELISTED
Oncorus, Inc.
ONCR
| $2.38M | ﹤0.01% |
1,891,592
+3,123
| +0.2% | +$4.24K |
|
5106
CALL
Shoals Technologies Group
SHLS
$1.42B
| $2.38M | ﹤0.01% |
144,500
-212,600
| -60% | -$3.14M |
|
5107
PUT
Guardant Health
GH
$21.1B
| $2.38M | ﹤0.01% |
59,000
-15,000
| -20% | -$743K |
|
5108
PUT
Huntington Bancshares
HBAN
$36.2B
| $2.38M | ﹤0.01% |
197,800
+25,800
| +15% | +$342K |
|
5109
CALL
SiTime
SITM
$21.4B
| $2.38M | ﹤0.01% |
14,600
-30,000
| -67% | -$5.67M |
|
5110
Thryv Holdings
THRY
$96M
| $2.38M | ﹤0.01% |
106,323
-13,830
| -12% | -$355K |
|
|
MBAC
5111
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $2.38M | ﹤0.01% |
242,598
+46,822
| +24% | +$459K |
|
|
CVAC
5112
CALL
DELISTED
CureVac
CVAC
| $2.38M | ﹤0.01% |
174,800
+43,200
| +33% | +$715K |
|
5113
Construction Partners
ROAD
$6.9B
| $2.38M | ﹤0.01% |
113,449
-68,744
| -38% | -$1.62M |
|
5114
PUT
Marqeta
MQ
$1.7B
| $2.37M | ﹤0.01% |
73,175
-18,700
| -20% | -$735K |
|
5115
PUT
New Fortress Energy
NFE
$92.6M
| $2.37M | ﹤0.01% |
60,000
+11,800
| +24% | +$508K |
|
5116
PUT
Relmada Therapeutics
RLMD
$512M
| $2.37M | ﹤0.01% |
125,000
+84,800
| +211% | +$1.85M |
|
5117
PUT
Frontier Group Holdings
ULCC
$1.54B
| $2.37M | ﹤0.01% |
253,200
+142,500
| +129% | +$1.44M |
|
5118
Wheels Up
UP
$182M
| $2.37M | ﹤0.01% |
6,081
+88
| +1% | +$47K |
|
5119
PUT
Vanguard FTSE Europe ETF
VGK
$31.1B
| $2.37M | ﹤0.01% |
44,900
-98,500
| -69% | -$5.71M |
|
5120
CALL
Silicon Motion
SIMO
$9.12B
| $2.37M | ﹤0.01% |
28,300
+1,100
| +4% | +$92.7K |
|
|
DOO
5121
Bombardier Recreational Products
DOO
$4.73B
| $2.37M | ﹤0.01% |
+38,494
| New | +$2.88M |
|
5122
James River Group Holdings
JRVR
$193M
| $2.37M | ﹤0.01% |
95,529
+7,608
| +9% | +$186K |
|
5123
TCW Transform 500 ETF
VOTE
$1.14B
| $2.37M | ﹤0.01% |
54,044
+6,380
| +13% | +$304K |
|
5124
CALL
Medifast
MED
$128M
| $2.37M | ﹤0.01% |
13,100
+900
| +7% | +$161K |
|
5125
Hyster-Yale Materials Handling
HY
$618M
| $2.36M | ﹤0.01% |
73,308
-8,484
| -10% | -$289K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.